艾昆纬-2025年全球健康进步指标（英）-2025.1_24页_2mb

报告摘要

2025 Indicators of Progress for Advancing Health Globally: Summary

Core Content

The IQVIA Institute for Human Data Science outlines seven key indicators to monitor progress in advancing global health in 2025. These indicators are designed to reflect measurable advancements in areas such as trust in healthcare and science, universal healthcare coverage, primary care expansion, and the use of innovative technologies like AI. The report emphasizes the importance of tracking these indicators to assess whether global health systems are moving forward, despite ongoing challenges and uncertainties.

Main Points

Cautious optimism is present in the global healthcare outlook for 2025, following the end of the COVID-19 pandemic, but threats from new diseases, economic stress, and unresolved health issues remain.
Trust in healthcare and science is a critical foundation for public health outcomes. The report highlights a significant decline in trust in physicians and hospitals, particularly in the U.S., which may impact vaccine uptake and public health initiatives.
Universal healthcare coverage (UHC) is a key priority, with the UHC Service Coverage Index expected to rise above 75/100 by the end of 2025 as a marker of progress.
Primary care is central to effective health systems. Efforts to expand primary care include developing national plans, increasing the workforce, and integrating digital health technologies.
Addressing long-standing health issues such as antimicrobial resistance (AMR) and pandemic preparedness requires tangible legislative and financial actions beyond discussions.
Precision in care delivery is crucial for improving health outcomes. The report highlights the underuse of effective treatments for non-communicable diseases like hypertension.
AI in drug development is a promising area with the potential to accelerate the discovery of new medicines, particularly for unmet medical needs.

Key Indicators of Progress

Indicator	Description
Trust in healthcare and science	Increase in the proportion of adults reporting "a lot" of trust in physicians and hospitals to at least 50%, up from 40% in 2024.
Public trust in science	Reversal of the downward trend in public trust in science, with more than 60% of U.S. adults reporting that science has a "mostly positive" impact on society.
Universal Health Coverage (UHC)	UHC Service Coverage Index rises above 75/100 by the end of 2025.
Primary care expansion	Number of countries with established plans or reforms to expand primary care, including explicit workforce targets.
Digital health strategies	Number of countries implementing digital health strategies for use in primary care settings.
Legislation on AMR	Passage of the PASTEUR Act by the U.S. Congress or similar legislative efforts to stimulate investment in novel antibiotics.
Pandemic Preparedness Treaty	Final resolution of the Pandemic Preparedness Treaty by WHO member states, ensuring a global framework for pandemic response.
Antibiotic subscription models	Adoption of subscription-based purchasing models for antibiotics by the European Union or other regions.
Hypertension treatment	A 5% increase in per capita defined daily doses of antihypertensive medicines used globally, with reduced disparities between middle-income and global average usage.
AI in drug development	Increase in the number of published papers on "disease interception" by at least 50% over 2024 levels, reflecting progress in AI-driven research.

Critical Insights

Trust restoration is a public health imperative, especially in light of the pandemic's impact on public perception of science and healthcare institutions.
UHC remains a major goal for the UN SDGs, and progress is essential for equitable access to healthcare services.
Primary care is a core component of health systems, and addressing the workforce shortage and integrating digital tools are key to its development.
AMR and pandemic preparedness are long-standing global health challenges that require concrete actions and investment, not just discussions.
Precision in care delivery and the use of AI in drug development are promising areas that may lead to faster, more effective treatments for diseases like hypertension.

Conclusion

These seven indicators provide a framework for evaluating progress in global health in 2025. They reflect both immediate and long-term goals, highlighting the need for a combination of policy, investment, and technological innovation to advance health outcomes worldwide. While the year ahead presents opportunities, it also underscores the urgency of addressing systemic challenges and rebuilding public confidence in healthcare institutions.

展开完整摘要